Prospective Database of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer

Brief description of study

Primary Objective: To record the treatment results and impact on clinical parameters following of Cryotherapy for ablation of clinically localized prostate cancer. Primary outcome variables of interest include PSA-progression free survival, histologic evaluation of treatment efficacy and imaging surveillance of treatment effects. Secondary Objectives: To determine the long-term urinary and sexual side effects following Cryo prostate ablation treatment. Background and Rationale Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this database is to prospectively collect data to assessing oncologic outcomes and urinary/sexual function after Cryoablation of prostate cancer with the intent to guide further research and improve patient care. Only patients of Herbert Lepor, M.D. and James Wysock, M.D. will be entered into this database.


Clinical Study Identifier: s17-00354
Principal Investigator: James S Wysock.
Other Investigators: Hossein Sadeghi-Nejad, Herbert Lepor, Wei Phin Tan.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.